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Edited by Takashi GojoboriAbstract We cloned a full-length androgen receptor (AR) cDNA
from chicken (Gallus gallus) gonads. The cDNA sequence has an
open reading frame of 2109 bp encoding 703 amino acids. The
chicken AR (cAR) shares high homology with ARs from other
species in its amino acid sequences, in particular DNA binding do-
main (DBD) and ligand binding domain (LBD). RT-PCR analysis
revealed that cAR mRNA is expressed in several embryonic tis-
sues of both sexes, and relatively higher expression was observed
in left ovary compared with testis. The immunoreactive signal of
ARwas co-localized within the ovarian cell nucleus, while such nu-
clear localization was not detected in those of testis. To get insight
on the possible role of androgen–AR signaling during gonadal
development, non-steroidal AR antagonist, ﬂutamide, was admin-
istrated in ovo. The treatment induced the disorganization of sex
cords in ovarian cortex at day 12 of incubation. The eﬀect was re-
stored by testosterone co-treatment, implying the possibility that
ARmediated signaling may be involved in ovarian morphogenesis.
Furthermore, co-treatment of ﬂutamide with estradiol-17b (E2)
also restored the phenotype, suggesting androgen–AR signaling
might activate aromatase expression that is necessary for estro-
gen synthesis. These ﬁndings suggest androgen–AR signaling
might contribute to chicken embryonic ovarian development.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Androgens play key roles in male character development of
vertebrates. They act through binding and activation of the
androgen receptor (AR), a ligand-dependent transcription fac-
tor that belongs to the steroid nuclear receptor superfamily
[1,2]. AR cDNAs have been cloned from several vertebrate
species. These AR sequences show a common structural orga-
nization and high homology in DNA-binding (DBD) and
ligand-binding domains (LBD) among species [3–6].
In birds, the homogametic sex (ZZ) which has been suggested
that the ‘default’ sex is male in contrast to that of mammals [7].
It has also been generally accepted that estrogens and its recep-
tors play critical roles in the sexual character development in
birds [8–12]. In female chicken, only the left gonad develops
into a functional ovary [13]. This asymmetric development in*Corresponding author. Fax: +81 96 373 6560.
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gested [9,8]. However, birds display striking male type sexual
characters in appendicular and gonadal developments, i.e.
comb, wattle, syrinx, urogenital tract, and testis. Androgens se-
creted by testis might participate in the developmental program
of hormone sensitive tissues in birds as well as mammals [14–
18]. However, the role of androgen–AR signaling has not been
elucidated in both male and female chicken embryogenesis. The
eﬀect of androgen on ovulation in an egg-laying hen is contro-
versial [19–22]. We have focused on the secondary sexual char-
acter development in both sexes, particularly androgen
dependent organogenesis in vertebrates [23–25].
Sex reversal is generally incompletely induced by hormonal
compound treatment or by mutation of sex steroid hormone
receptor genes in mammals. Mammalian sex determination is
initiated by the expression of Y-chromosomal SRY gene
[26]. Subsequent sex diﬀerentiation is accelerated by sex steroid
hormones secreted from gonads. On the other hand, aromatase
inhibitor which inhibits the conversion of androgen to estrogen
induces female-to-male sex reversal in chicken [11,27,28].
Hence, chicken sex determination factors are still unclear in
such aspects. There is controversy as to the eﬀect of the sex ste-
roid hormones contained in the yolk on sex determination. It
has been, therefore, generally considered that the developmen-
tal processes of sexual character are not strictly subdivided
into the genetically and hormonally regulated phases. As a fac-
tor related to such two phases, AR converts sex steroid hor-
mone signals to target gene expression.
In this paper, we ﬁrst identiﬁed chicken AR (cAR) cDNA
containing the full-length open reading frame (ORF) and
examined its sexually dimorphic expression in chicken em-
bryos, particularly in gonadal development. The transactivat-
ing function of cAR was determined by expressing its cDNA
in kidney-derived cell line COS-7. To get insight on the AR
functions during chicken embryogenesis, we administrated
the ﬂutamide [29–31] into the eggs after sex determination
stage [12,32–34]. It was revealed that histological organization
of the sex cords in left ovary was aﬀected by ﬂutamide treat-
ment. Possible involvement of androgen–AR signaling in ovar-
ian development is discussed.2. Materials and methods
2.1. RNA isolation and RT-PCR analysis
Total RNA was extracted from chicken gonads by acid guanidinium
thiocyanate-phenol-chloroform (AGPC) method (Nippon Gene,
311–02501). To obtain the cDNA fragment of cAR, oligonucleotideblished by Elsevier B.V. All rights reserved.
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conserved DBD and LBD of ARs. RT-PCR was carried out using
SuperScript One-Step RT-PCR with PLATINUM Taq System (Invit-
rogen, 12574–026). The primers used in this study yielded a 510 bp
fragment homologous to human AR. Their sequences are as follows;
dS-1:CTCACCTGYGGHAGCTGCAA and dAS-1:CCATCCARG-
ARTRCTGGAT. Ampliﬁed products of expected size were cloned
into pGEM-T Easy Vector (Promega, A1360) and sequenced. To
analyze the expression of cAR, oligonucleotide primers were designed
based on the obtained sequence as follows; qS-1:CCATCGACAA-
GTTCAGGAGG and qAS-1:GACATCTGGTCATCCACATGC.
Subsequently, RT-PCR analysis was performed on total RNA from
testes, left ovaries and various tissues of chicken embryos. At each data
point, ﬁve chicken embryos were utilized and similar results were ob-
tained in three separate experiments. Ampliﬁcation of b-actin was per-
formed in all experiments as an internal control.
2.2. Isolation of chicken full length AR cDNA
Based on the sequence informations of obtained PCR products, the
5 0 and 3 0 ends of cAR sequences were ampliﬁed using the rapid ampli-
ﬁcation of cDNA end kit (Gene Racer kit) [35] essentially as detailed
by manufacturer’s instruction (Invitrogen, L1502-01). Poly (A)+
RNA was prepared from the gonads using Oligotex-MAG mRNA
Puriﬁcation kit (TaKaRa, 9087). Obtained cDNAs were subjected to
5 0-RACE with TaKaRa LA Taq (TaKaRa, RR02AG) and 3 0-RACE
with Platinum Taq DNA Polymerase High Fidelity (Invitrogen,
11304-011) using gene speciﬁc primers for cAR, rS-1(GAAG-
TACCTGTGTGCCAGCCGAAA) and rAS-1(GGAGAAGGAGT-
CTGGCTGGCTGTT) with the supplied adapter speciﬁc primers,
GeneRacer 5 0 primer (CGACTGGAGCACGAGGACACTGA) and
GeneRacer 3 0 primer (GCTGTCAACGATACGATACGTAACG).
The ampliﬁed products were cloned and sequenced. Subsequently,
RT-PCR analysis was performed using coding terminal primers,
fS-1(ATGGAGGTGCAGCTGGGGATCG) and fAS-1(TCACTCC-
GCGTGGAAGTAAATG) to conﬁrm that the two RACE products
correspond to an identical clone. Obtained full-length cAR cDNA
was cloned into pGEM-T Easy vector and sequenced. Clustal analysis
was performed using the CLUSTAL W software [36].
2.3. Phylogenetic analysis
Phylogenetic analysis of AR genes was performed on the amino
acid sequences (228 residues, excluding positions with a gap) of C-
terminal regions mainly composed of the DBD and LBD. Estima-
tion of molecular phylogeny was carried out by the neighbor-joining
method [37] using the CLUSTAL W program. Conﬁdence in the
phylogeny was assessed by bootstrap resampling of the data
(1000) [38].
2.4. Transient transfection assay
The entire protein coding region of cAR cDNA was ampliﬁed by
RT-PCR using the primers, cAR-CDS-S1 (ATGGAGGTGCAGT-
TAGGGCTGG), cAR-CDS-A1 (CTGTGTGTGGAAATAGATGG-
GCTTG) and then inserted into a CMV expression vector (pCS2+MT)
[39,40] to yield pCMV-cAR. The mouse AR (mAR) cDNA ampliﬁed
by RT-PCR was cloned into pCS2+MT, producing the pCMV-mAR.
A reporter plasmid for AR (pGL3 PRE/ARE tk Luc) was provided by
Dr. Shigeaki Kato (University of Tokyo, Japan) [41].
COS-7 cells cultured in 24-well multi-well plates (5.0 · 104 cells
per well), were transfected with 400 ng/well of PRE/ARE reporter
plasmid, 0.8 ng/well of pRL-SV40 (a Renilla luciferase vector) as
the internal control, and 80 ng/well of the expression vector for
the cAR or mAR, using 1.5 ll/well of TrasFast Transfection Re-
agent (Promega, E2431). Starting after 6 h of transfection, the cells
were incubated for 12 h in DMEM with 0.2% FCS in the presence
or absence of 109 M 5a-dihydrotestosterone (DHT, Wako Chemi-
cal, 045-26071), testosterone (T, Wako Chemical, 204-08343),
Androstenedione (A, Sigma, A-9630), 11-ketotestosterone (11KT,
Sigma, K-8250), ethynyl testosterone (ET, Sigma, E-1001), ﬂutamide
(Sigma, F-9397), or estradiol-17b (E2, NACALAI TESQUE INC.,
145-41). The cells were then solubilized with 200 ll of lysis buﬀer
(Promega) and the reporter gene activities were determined by
Dual-Luciferase Reporter Assay System (Promega, E1910) as values
normalized by pRL-induced activities, i.e. (ﬁreﬂy luciferase activity)/
(Renilla luciferase activity). All experiments were repeated at leastthree times. The data are presented as the means ± S.D. Immunocy-
tochemical staining was performed using rabbit polyclonal anti-AR
antibody (Santa Cluz, AR-N20, sc816) as described bellow. The nu-
clei were stained with bisbenzimide H33342 (Hoechst 33342, Sigma,
B2261) (2 lg/ml).
2.5. Immunohistochemistry
Chicken embryonic samples were ﬁxed in 4% paraformaldehyde/
PBS, and embedded with paraﬃn. Sections for histological analyses
were prepared by standard procedures. For antigen retrieval, slides
were autoclaved with 10 mM citrate buﬀer pH 6.0, cooled to room
temperature and rinsed with PBS. Sections were incubated with
blocking solution (2% Blocking reagent (Roche, 1096176)) for 2 h.
They were incubated at 4 C in a humidity chamber with the rabbit
polyclonal anti-AR antibody diluted at 1/40 in blocking solution
overnight. Sections were washed three times in PBS, then incubated
with the second antibody (Alexa Fluor 546-Goat Anti-Rabbit IgG
(Molecular probes, A-11010)) at 1/200 dilution in blocking solution
for 1 h at room temperature. After washing with PBS, the sections
were stained with 2 lg/ml Hoechst 33342 for 5 min. For immunohis-
tochemical analysis of the cloaca and syrinx, anti-rabbit IgG-AP
(diluted at 1/200 in blocking solution, Boehringer Mannheim
GmbH) was used as the second antibody for alkaline phosphatase
reaction with AP substrate (BM Purple AP substrate, Roche,
1442074) for 1 h. Staining without the primary antibody was
performed as negative control. Samples were analyzed using Nikon
microscope (BX50) with appropriate excitation/emission ﬁlters. The
images were captured using Olympus DP70 camera.
2.6. Administration of hormonal substrates and antagonist
Fertilized White Leghorn chicken eggs were purchased from Marui
Farm Co. (Japan). Eggs were incubated at 38.0 C. After windowing
the egg shell, a hole was sealed with a piece of adhesive tape. Stock
solutions for ﬂutamide, T and estradiol-17b were dissolved in ethanol
at 100, 100, and 25 mg/ml, respectively, mixed with 300 ll corn oil and
injected in ovo. At day 7 of incubation, 0.25 mg ﬂutamide was injected
into the yolk. Co-treatment of 0.25 mg ﬂutamide with 0.25 mg T or
0.25 mg estradiol-17b was also carried out. At day 12 of incubation,
embryos were killed and gonads were examined for histological and
gene expression analyses.
To examine the eﬀect of ﬂutamide on aromatase expression in
ovary, competitive RT-PCR analysis was performed. A set of prim-
ers was designed to amplify a 693 bp fragment of aromatase gene
[42] and competitor fragment was designed to yield 172 bp internal
deletion. Estimation of the expression levels by competitive RT-PCR
was repeated adjusting until the competitor levels matched to that of
the target with diﬀerences less than 10% using NIH Image program
ver. 1.55.
2.7. Administration of aromatase inhibitor
Aromatase inhibitor (Fadrozole, Novertis Pharma) was dissolved in
0.9% NaCl at 10 mg/ml. At day 7 of incubation, 0.1 mg aromatase
inhibitor was administrated in the windowed egg. At the day 12 of
incubation, the embryos were sacriﬁced and sampled.3. Results
3.1. Isolation of cAR cDNA
A partial AR cDNA was obtained by RT-PCR from chicken
gonadal RNA using degenerate primers designed from the
highly conserved region of AR proteins of various species.
The cAR cDNA containing an ORF was ampliﬁed by 5 0-
and 3 0-RACE PCR using cAR gene-speciﬁc primers designed
from the partial cDNA sequence. The obtained cAR cDNA
of 4974 bp contained an ORF of 2109 bp ﬂanked by 363 and
2502 bp of 5 0- and 3 0-UTRs, respectively (GenBank Accession
No. AB193190) (Fig. 1A). The polyadenylation signal (AA-
TAAA) was included in 3 0-UTR sequence, 14 bases upstream
from the ﬁrst A of the poly A tract.
Fig. 1. Structure of cAR cDNA. (A) cAR cDNA sequence. The numbers on the right and left correspond to the positions of nucleotides and deduced
amino acids, respectively. (A) broken-line box indicates the DBD. Eight cysteine residues constitute the zinc ﬁnger motifs (marked with an asterisk).
‘P box’ and ‘D box’ are marked with an underline, respectively. The LBD region is indicated by a solid-line box. Leucine and valine residues included
in the leucine zipper motif are marked with a plus sign. The TGA translation-terminal codon is marked with a dot. (B) Comparison of deduced amino
acid sequence of cAR with ARs of other species. Several distinct domains included in the AR protein are schematically represented with the numbers
of amino acid residues indicated above boxes. The CLUSTAL W software was used to align the amino acid sequences of each domain. The numbers
within each box indicate the homology of the domain by percentage relative to cAR. Sequences were retrieved from GenBank: human AR (M23263),
mAR (M37890), frog (Xenopus leavis) AR (U67129), tilapia (Oreochromis niloticus) AR a (AB045211), and b (AB045212). (C) Phylogenetic trees of
chicken (Gallus gallus; AB193190), canary (Serinus canaries; L25901), zebra ﬁnch (Taeniopygia guttata; AF532914), and quail (Coturnix japonica;
AB188828), together with green anole (Anolis carolinensis; AF223224) as an outgroup, using putative amino acid sequences of AR. Available
sequence region of each species indicated a closed box in right. Branched length is proportional to the number of amino acid substitutions and the
scale bar indicates 0.01 amino acid substitution in the sequence.
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We compared the deduced amino acid sequence of cAR with
those of other ARs identiﬁed in several species. The amino acid
identities of cAR with human, mouse, frog (Xenopus leavis),
tilapia (Oreochromis niloticus) a and b ARs are 55%, 52%,
56%, 34%, and 40%, respectively. Obtained cAR cDNA se-
quence could be subdivided into four domains as deﬁned by
Krust et al. [43]. Comparisons of three characteristic domains
of cAR with those of other species revealed that the N-termi-
nal domain (NTD) sequences were divergent in several species,
sharing homology ranging from 32% with frog to 10% with
tilapia a (Fig. 1B). The AR NTD sequences of any bird species
had not been completely identiﬁed, though most of AR trans-
activation activity is thought to be mediated via the NTD
[44,45]. The NTD of cAR is shorter than those of mammalian
ARs, however some motifs recently identiﬁed in mammalian
ARs were conserved in cAR sequences. The FxxLF sequence
is known to mediate the interaction between the NTD and
LBD that is thought to facilitate AR dimerization, stabilize
androgen binding, and possibly regulate AF-1 and AF-2 activ-
ity [46–48]. In cAR NTD, 23FQTFF27 sequence was identiﬁed
in the same position of the FxxLF sequence of mammalian
ARs. The AR NH2-terminal conserved motif that is identiﬁed
as the Hsp70-interacting protein interacting site (human AR
residues 234–247) was conserved in cAR (residues 127–140).
The CAG triplet repeats whose expansion aﬀect AR activity
[49] was not included in cAR. The AR NTD is thought to
be responsible for the cell- and ligand-speciﬁc regulation of
the target genes. Further sequence information of other birds’
ARs, in particular NTD, will be necessary as a comparison to
assess the role of cAR in the morphologically diversiﬁed sexual
characters in birds.
In contrast, DBD and LBD of cAR show high homology
with ARs of other species, sharing 66–98% amino acid identity
in DBD, and 60–92% in LBD. In the DBD of cAR, eight cys-
teine residues constituting two zinc ﬁnger motifs, ‘P box’
(GSCKV), and ‘D box’ (ASRND) are also conserved in several
nuclear receptors, both of which are known as important for
recognition and binding of the hormone responsive element
of AR target genes [50]. Putative leucine zipper motif, which
is considered to be required for dimerization of ARs [51], is
conserved in cAR LBD. Amino acids with possible interaction
with DHT in human AR (N705, Q711, R752 and T877) [52]
were conserved in cAR LBD (the cAR residues N489, Q495,
R536 and T661). The hAR residue R779 that is a critical com-
ponent of the architecture of the AR [53] is also conserved in
cAR (R563).
Phylogenetic analysis using AR putative amino acid se-
quences among four species of birds indicated that chicken is
conventionally classiﬁed as belonging to the same group of
quail as Galliformes (Fig. 1C).
3.3. Tissue distribution of AR mRNA in chicken embryos
The cAR mRNA was expressed in various tissues of both
sexes at embryonic day 15 (Fig. 2A). Signiﬁcant diﬀerences
in the AR expression levels between male and female were
observed in sexually diﬀerentiating gonads. The AR expres-
sion levels at syrinx and gonads in female were higher than
those of male. Such sexual diﬀerences of AR expression lev-
els were not prominent in other tissues. The AR expression
levels temporally increased in developing testis and leftovary (Fig. 2B and C). The AR expression in the left ovary
was maintained signiﬁcantly higher than that of the testis
throughout embryonic days examined. At day 13 of incuba-
tion, the AR expression was markedly increased in male go-
nad. In female, AR expression was maintained, and slightly
increased during day 7–17. At prehatch stage of day 21, the
gonadal AR expressions exhibited highest level in both male
and female.
3.4. Distribution of AR protein in sexually dimorphic tissues
Gasc and Stumpf revealed that a large number of androgen
target cells distributes in the cloacal region at day 15 of chicken
embryos [16]. At this stage, chicken gonad has an ability to
produce T [54]. Hence, we performed immunohistochemical
analysis using AR antibody at day 15 of incubation. AR pro-
tein was widely distributed in the developing testis and ovary
(Fig. 3F and H). Many AR signals were localized in nuclei
of the ovary (Fig. 3F). Uneven staining of nuclei with Hoechst
33342 was observed in the ovarian cells. The AR immunoreac-
tive signals were often distributed in the less-dense stained
areas of nucleus with Hoechst 33342 (Fig. 3G). In contrast,
such nuclear localized signals could not be detected in the tes-
tis, although AR proteins were distributed in the developing
testicular cords (Fig. 3H and I).
The AR expression was observed in male wolﬃan duct,
peripheral regions of male cloaca which presumably develops
into the prospective lymphobulbus (Fig. 3-J), while it could
not be detected in the female cloaca (data not shown). In the
syrinx at late embryonic stage, the AR was expressed at the
membrana externa and bilateral regions of pessules in both
male and female (Fig. 3K and L). Previous reports pointed
that sex steroid hormones and its receptors, particularly estro-
gen and estrogen receptors, participate in syrinx development
of both sexes. Expression of AR in this organ raises the possi-
bility that cells within this organ might also respond to andro-
gen. The AR protein positive organs identiﬁed in this study
corresponds to organs that are thought to appear the second-
ary sexual characters [13,16,55].
3.5. Transactivating function and intranuclear localization of
cAR
To conﬁrm the androgen-dependent transactivating function
of cAR, COS-7 cells, transiently transfected with cAR expres-
sion vector (pCMV-cAR) together with the reporter construct
containing androgen response elements (pGL3 PRE/ARE tk
Luc), were treated with 109 M various steroids or non-steroi-
dal AR antagonist, ﬂutamide (Fig. 4A). In mammals, T and
DHT are considered to be the eﬀective ligands for AR [56].
Both T and DHT induced signiﬁcant increase of luciferase
activity via cAR in COS-7 cells. 11KT was also eﬀective, but
its potency was lower than those of DHT and T. Treatment
of ﬂutamide or estradiol-17b (E2) did not induce such transac-
tivation. Ligand speciﬁcity of cAR was similar to that of mAR,
which may correspond to the sequence conservation of the
amino acids that have possible hydrogen bonds with DHT
[52]. In addition, DHT stimulated luciferase activity in a
dose-dependent manner (Fig. 4B).
The distribution of cAR was found to be translocated in the
nucleus, when transfected COS-7 cells were treated with 109
M DHT, as observed for the case of mAR transfection
(Fig. 4C).
Fig. 2. Spatial and temporal expression of cAR. (A) Expression of AR mRNA in chicken embryonic tissues at day 15 of incubation. The cAR
expressions in male brain, heart, liver, intestine, and mesonephros, and in the syrinx and gonad of both sexes were analyzed by RT-PCR. Left ovary
was used for RNA extraction. RT-PCR analysis showed that the expression levels of AR in brain, heart, liver, intestine, and mesonephros were
similar between male and female. m, male; f, female. (B) The time course of cAR expression during embryonic development of gonads. Total RNA
was isolated from gonads during 7th–21st days of incubation, and subjected to RT-PCR. At each incubation time, right and left lanes indicated the
ovary and testis RNAs, respectively. Ov, ovary. Ts, testis. (C) High level cAR expression persisted in the developing ovary compared with testis. The
relative expression levels of cAR were estimated from the intensity of bands in panel B compensated by b-actin expression levels using NIH Image
program ver. 1.55. The cAR expression of representative data points was also conﬁrmed by real time quantitative PCR analysis (data not shown).
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The ﬁrst signs of sexual diﬀerentiation in gonad are observed
as the sex cord formation in the cortex of ovary [13]. The sex
cord like structures were observed as a cluster of cortex cells
in the developing ovary at day 12 of incubation (Fig. 5A).
We examined the eﬀects of ﬂutamide to sex cord formation as
an indicator of gonadal diﬀerentiation. The cluster of cortex
cells was disrupted by ﬂutamide treatment (Fig. 5B). To con-
ﬁrm such disorganization of the sex cords was induced by func-
tional antagonism of androgen–AR signaling, we performed
the co-treatment of ﬂutamide with T. The sex cord formation
was restored by the co-treatment in the ovary (Fig. 5C). Next,
we administrated E2 with ﬂutamide to examine whether cAR is
involved in the metabolism of T to E2. The co-treatment of ﬂu-
tamide with E2 restored the sex cord formation (Fig. 5E). The
disorganization of the sex cords was induced by the treatment
of aromatase inhibitor (Fig. 5D). Similar results were obtainedby ﬂutamide or aromatase inhibitor treatments in the ovary
(Fig. 5B and D). Aromatase gene expression in the developing
ovary was inhibited by the ﬂutamide treatment compared with
controls (Fig. 5F). These results indicate that aromatase expres-
sion may be under the inﬂuence of androgen actions in the
developing ovary. In male embryo, the treatment of ﬂutamide
did not induce signiﬁcant histological diﬀerences compared
with control (data not shown). Our observation suggests that
ﬂutamide treatment does not aﬀect male chicken embryonic go-
nadal development in the current experimental conditions.4. Discussion
In 1849, the ﬁrst endocrinological analysis of androgenic
function of chicken testis was published by Berthold [57]. He
transplanted chicken testes on the castrated male chicken.
Fig. 3. Immunohistochemical analysis of AR expression in chicken gonad, cloaca, and syrinx. AR expression was examined by AR antibody staining
(F–L) at day 15 of incubation. Sections were stained with hematoxylin and eosin (A–E). Transverse sections of chicken ovary (A,F,G), testis (B,H, I),
peripheral cloaca of male (C,J), and median frontal sections through tracheobronchial region (syrinx) of male (D,K) and female (E,L). Arrowhead
(Wolﬃan duct) and arrows indicate AR immunoreactive regions. F and H panels were stained with a ﬂuorescent antibody against AR (red), and a
DNA-speciﬁc dye (blue, Hoechst 33342) to indicate nuclei. G and I show the boxes in F and H, respectively, at higher magniﬁcation. Scale bar
(A,B,F,H): 50 lm, (G,I): 10 lm, (C,J) and (D,E,K,L): 0.5 mm. Ct, cortex; M, medulla; C, cloaca; WD, Wolﬃan duct; U, ureter; P, pessules; ME,
membrana externa; B, ﬁrst bronchial cartilagious semiring; T, ﬁrst tracheal ring.
Fig. 4. Ligand-dependent transactivation proﬁles of cAR and mAR. (A) Ligand dependent transactivation capacities of cAR. The COS-7 cells were
transfected with either pCMV-cAR, pCMV-mAR, or pCS2-MT as control vector, and pGL3 PRE/ARE tk Luc as a reporter plasmid. pRL-SV40
was used as an internal control for normalization of transfection eﬃciency. Tranfected cells were treated with the 109 M of various steroids and
compound (DHT, 5a-dihydrotestosterone; T, testosterone; A, androstenedione; 11KT, 11-ketotestosterone; ET, ethynyl testosterone; F, ﬂutamide;
E2, estradiol-17b). The relative transactivation activity of AR was expressed as values normalized by pRL-induced activities. (B) Dose–response
proﬁle of cAR activation by DHT. The transfected cells were incubated with increasing concentrations of DHT (1011–107 M) or without ligand for
12 h. (C) Immunocytochemistry of AR. COS-7 cells were transiently transfected with pCMV-cAR or pCMV-mAR. Immunostaining of AR was
detected after incubation in FCS-free medium with the absence and presence of 109 M DHT. Shown are the merged images of red ﬂuorescenece for
AR and blue ﬂuorescence of nuclear staining by Hoechst 33342.
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Fig. 5. Eﬀects of hormonal compounds or aromatase inhibitor on the developing ovary. Histological appearance of ovarys at day 12 of incubation
that were treated with vehicle (A), 0.25 mg ﬂutamide (B), 0.25 mg ﬂutamide and 0.25 mg T (C), 0.1 mg fadrozole (D), or 0.25 mg ﬂutamide and
0.25 mg E2 (E). White bar indicates cortex region. Arrowheads mark sex cords. Bar = 0.1 mm. (F) Comparison of aromatase gene expression
between ﬂutamide treated ovary and controls at day 12 by competitive RT-PCR analysis (n = 3 for each experiment). Bars represent the relative
expression levels (means ± S.D.) in three separate experiments where the control is adjusted to 100. *, statistically signiﬁcant diﬀerences compared
with controls were conﬁrmed (P < 0.01).
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ter and behaved more aggressive. It was the ﬁrst evidence
showing the presence of male hormone secreted from testis
and its action for the secondary sexual characters.
Birds show the diversiﬁed sexual characters development in
appendicular and gonadal organs [58]. However its regulatory
mechanism by AR has not been elucidated. Here, we cloned
the complete coding sequence of the cAR cDNA. This is the
ﬁrst full length coding AR cDNA in chicken and also in birds.
The study also demonstrated the full length cAR cDNA pos-
sesses transactivating function assayed by in vitro analysis.
Thus this cAR full length cDNA is expected to serve as an
eﬀective tool for functional AR gene assay in birds.
The deduced cAR sequence could be subdivided into the
NTD, conserved DBD and LBD. We examined its ligands
dependent transactivation function. T and DHT were eﬀective
in inducing luciferase activity and nuclear localization of cAR.
Thus, the cloned cDNA encodes a functional cAR and T and
DHT act as the ligands for cAR.
Our gene expression analysis revealed that cAR expression in
ovary maintained at higher level than that in the testis
throughout the gonadal development. The AR immunoreac-
tive signals were localized in many nuclei of ovarian cells, while
nuclear localization could not be detected in the case of testis.
Functional antagonism to AR signaling by ﬂutamide treat-
ment induced the disorganization of the sex cords in embry-
onic ovary at day 12 of incubation. Such disorganization
was not due to a toxic eﬀect of ﬂutamide, but to the inhibition
of androgen–AR signaling, because the sex cords were restored
by co-treatment of ﬂutamide with T. Signiﬁcant histological
diﬀerences could not been detected between ﬂutamide treated
testis and control (data not shown). These results may be in
accordance with the hypothesis that androgen–AR signalingmight be activated, and facilitates the androgen dependent
transactivation of target genes in the developing ovary, but
not in the testis. The higher level of T in developing ovary than
testis [15,17,54] supports this hypothesis. Further molecular
developmental studies including functional assays will be re-
quired to access cAR function during gonadal development.
Furthermore, E2 was treated with ﬂutamide to examine its
eﬀects on the sex cord formation. It has been thought that
AR protein has a low aﬃnity to E2 [59], and E2 treatment does
not induce nuclear import of AR [5]. In addition, E2 did not
exert cAR-dependent transactivation in COS-7 cells. The sex
cords were formed in E2-treatment, despite the inhibition of
AR signaling by ﬂutamide. This observation suggests E2
may have more roles than T in the developing ovary, as de-
scribed that estrogens have a key role in ovarian development
[8,10,42].
Aromatase is required for the synthesis of estrogen by cata-
lyzing estrogen from androgen. Aromatase inhibitor has been
previously shown as a potent and speciﬁc inhibitor of aroma-
tase enzyme and it induces female-to-male sex reversal in chick-
en [11,60]. Inhibition of aromatase activity with aromatase
inhibitor and the functional antagonism of androgen–AR sig-
naling by ﬂutamide induced similar defects of sex cord forma-
tion in the developing ovary. These observations suggest a
possibility that T as substrate via ARmight upregulates aroma-
tase expression during the formation of sex cords in the devel-
oping ovary. Using competitive RT-PCR analysis, aromatase
expression was detected in the ovary, which was decreased by
ﬂutamide treatment (Fig. 5F). We also performed an in silico
analysis of chicken aromatase (CYP19A1) 5 0 ﬂanking sequence
(GenBank Accession No. NW_060456: based on the current
information), which revealed the presence of at least four sim-
ilar ARE within 20 kb upstream to the transcription start site.
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5 0 ﬂanking region, together with our ﬁnding that antagonism of
AR results in reduction of aromatase expression in left ovary,
suggests the possibility that aromatase could be regulated by
AR.
Aromatase expression is important for the morphological
diﬀerentiation of ovary in female [33]. The level of aromatase
gene expression in the ovary was signiﬁcantly higher than that
in the testis during the chicken gonadal development by our
real time quantitative PCR analysis (data not shown; also re-
ported by [8,61]). Concerning about aromatase gene regulation
by androgen, we believe that AR aﬀects aromatase gene
expression in concert with other factors. Indeed, despite the
AR expression in both testis and ovary, aromatase expression
could not be detected by RT-PCR in chicken testis at day 12
of incubation (data not shown).
The heterogametic sex is the male (XY) in mammals and the
female (ZW) in birds. In mammals and birds, the homogametic
sex is thought as the ‘default’ sex, and the diﬀerentiation of
these embryos seems to proceed in the absence of sex-speciﬁc
hormones at post-sex determination period. In contrast, the
diﬀerentiation of the heterogametic sex, which is female in
birds and male in mammals, is accelerated by sex-speciﬁc hor-
mones secreted from gonads. We observed that AR was ex-
pressed at lower level in embryonic gonads of male than
female, and its expression reached higher at prehatching stage
in male embryonic gonads. Tanabe et al. reported that T con-
tent of embryonic testes increased at hatching [15]. Such in-
crease of AR expression and T synthesis in testis indicates
that androgen–AR signaling might accelerate the masculiniza-
tion for male chicken after hatching. Androgens act as a com-
mon male hormone for vertebrates, although there are
variations of gametic types in vertebrates. Our obtained results
suggest that androgen–AR signaling is involved in the female
chicken gonadal development.
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